Coprinus comatus Cap Inhibits Adipocyte Differentiation via Regulation of PPAR[gamma] and Akt Signaling Pathway

• Published in: PloS one 2014-09, Vol.9 (9)
• Main Authors: Park, Hyoung Joon, Yun, Jisoo, Jang, Sun-Hee, Kang, Suk Nam, Jeon, Beong-Sam, Ko, Yeoung-Gyu, Kim, Hong-Duck, Won, Chung-Kil, Kim, Gon-Sup, Cho, Jae-Hyeon
• Format: Article
• Language: English
• Subjects: Body weight; Lipoprotein lipase; Obesity; Protein binding; Triglycerides
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0105809

This study assessed the effects of Coprinus comatus cap (CCC) on adipogenesis in 3T3-L1 adipocytes and the effects of CCC on the development of diet-induced obesity in rats. Here, we showed that the CCC has an inhibitory effect on the adipocyte differentiation of 3T3-L1 cells, resulting in a significant decrease in lipid accumulation through the downregulation of several adipocyte specific-transcription factors, including CCAAT/enhancer binding protein [beta], C/EBP[delta], and peroxisome proliferator-activated receptor gamma (PPAR[gamma]). Moreover, treatment with CCC during adipocyte differentiation induced a significant down-regulation of PPAR[gamma] and adipogenic target genes, including adipocyte protein 2, lipoprotein lipase, and adiponectin. Interestingly, the CCC treatment of the 3T3-L1 adipocytes suppressed the insulin-stimulated Akt and GSK3[beta] phosphorylation, and these effects were stronger in the presence of an inhibitor of Akt phosphorylation, LY294002, suggesting that CCC inhibited adipocyte differentiation through the down-regulation of Akt signaling. In the animal study, CCC administration significantly reduced the body weight and adipose tissue weight of rats fed a high fat diet (HFD) and attenuated lipid accumulation in the adipose tissues of the HFD-induced obese rats. The size of the adipocyte in the epididymal fat of the CCC fed rats was significantly smaller than in the HFD rats. CCC treatment significantly reduced the total cholesterol and triglyceride levels in the serum of HFD rats. These results strongly indicated that the CCC-mediated decrease in body weight was due to a reduction in adipose tissue mass. The expression level of PPAR[gamma] and phospho-Akt was significantly lower in the CCC-treated HFD rats than that in the HFD obesity rats. These results suggested that CCC inhibited adipocyte differentiation by the down-regulation of major transcription factor involved in the adipogenesis pathway including PPAR[gamma] through the regulation of the Akt pathway in 3T3-L1 cells and HFD adipose tissue.